Eqis Capital Management, Inc. Karyopharm Therapeutics Inc. Transaction History
Eqis Capital Management, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Eqis Capital Management, Inc. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 38,684 shares of KPTI stock, worth $23,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,684
Previous 37,201
3.99%
Holding current value
$23,210
Previous $30,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KPTI
# of Institutions
94Shares Held
59.6MCall Options Held
547KPut Options Held
67K-
Vanguard Group Inc Valley Forge, PA7.65MShares$4.59 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$3.79 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$2.94 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$2.11 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $47.9M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...